Literature DB >> 33531650

Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.

Taraprasad Das1, Rajagopalaboopathi Jayasudha2, SamaKalyana Chakravarthy2, Gumpili Sai Prashanthi2, Archana Bhargava3, Mudit Tyagi1, Padmaja Kumari Rani1, Rajeev Reddy Pappuru1, Savitri Sharma2, Sisinthy Shivaji4.   

Abstract

Gut bacterial microbiome dysbiosis in type 2 Diabetes Mellitus (T2DM) has been reported, but such an association with Diabetic Retinopathy (DR) is not known. We explored possible link between gut bacterial microbiome dysbiosis and DR. Using fecal samples of healthy controls (HC) and people with T2DM with/without DR, gut bacterial communities were analysed using 16S rRNA gene sequencing and data analysed using QIIME and R software. Dysbiosis in the gut microbiomes, at phyla and genera level, was observed in people with T2DM and DR compared to HC. People with DR exhibited greater discrimination from HC. Microbiomes of people with T2DM and DR were also significantly different. Both DM and DR microbiomes showed a decrease in anti-inflammatory, probiotic and other bacteria that could be pathogenic, compared to HC, and the observed change was more pronounced in people with DR. This is the first report demonstrating dysbiosis in the gut microbiome (alteration in the diversity and abundance at the phyla and genera level) in people with DR compared to HC. Such studies would help in developing novel and targeted therapies to improve treatment of DR.

Entities:  

Year:  2021        PMID: 33531650     DOI: 10.1038/s41598-021-82538-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  76 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 3.  Human nutrition, the gut microbiome and the immune system.

Authors:  Andrew L Kau; Philip P Ahern; Nicholas W Griffin; Andrew L Goodman; Jeffrey I Gordon
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

4.  The microbiome revolution.

Authors:  Martin J Blaser
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

5.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

Review 6.  Gut Microbiota in Cardiovascular Health and Disease.

Authors:  W H Wilson Tang; Takeshi Kitai; Stanley L Hazen
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

Review 7.  The human microbiome: at the interface of health and disease.

Authors:  Ilseung Cho; Martin J Blaser
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

8.  Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site.

Authors:  Reiko Horai; Carlos R Zárate-Bladés; Patricia Dillenburg-Pilla; Jun Chen; Jennifer L Kielczewski; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Hidehiro Yamane; Kenya Honda; Rachel R Caspi
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

9.  We are not alone: a case for the human microbiome in extra intestinal diseases.

Authors:  S Shivaji
Journal:  Gut Pathog       Date:  2017-03-07       Impact factor: 4.181

10.  Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes.

Authors:  Matej Oresic; Satu Simell; Marko Sysi-Aho; Kirsti Näntö-Salonen; Tuulikki Seppänen-Laakso; Vilhelmiina Parikka; Mikko Katajamaa; Anne Hekkala; Ismo Mattila; Päivi Keskinen; Laxman Yetukuri; Arja Reinikainen; Jyrki Lähde; Tapani Suortti; Jari Hakalax; Tuula Simell; Heikki Hyöty; Riitta Veijola; Jorma Ilonen; Riitta Lahesmaa; Mikael Knip; Olli Simell
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

View more
  20 in total

Review 1.  Gut Microbes and Eye Disease.

Authors:  Patrick Donabedian; Elizabeth Dawson; Qiuhong Li; Jinghua Chen
Journal:  Ophthalmic Res       Date:  2021-12-16       Impact factor: 3.031

2.  The blue circle and 100 years of insulin discovery.

Authors:  Taraprasad Das; Padmaja K Rani; Sobha Sivaprasad; Rajiv Raman
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

3.  PET microplastics affect human gut microbiota communities during simulated gastrointestinal digestion, first evidence of plausible polymer biodegradation during human digestion.

Authors:  Alba Tamargo; Natalia Molinero; Julián J Reinosa; Victor Alcolea-Rodriguez; Raquel Portela; Miguel A Bañares; Jose F Fernández; M Victoria Moreno-Arribas
Journal:  Sci Rep       Date:  2022-01-11       Impact factor: 4.379

Review 4.  Gut Microbiota and Complications of Type-2 Diabetes.

Authors:  Camelia Oana Iatcu; Aimee Steen; Mihai Covasa
Journal:  Nutrients       Date:  2021-12-30       Impact factor: 5.717

Review 5.  Emerging Interrelationship Between the Gut Microbiome and Cellular Senescence in the Context of Aging and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Rohit Sharma
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-05       Impact factor: 5.265

6.  Altered Fecal Microbiome and Metabolome in a Mouse Model of Choroidal Neovascularization.

Authors:  Yun Li; Yuting Cai; Qian Huang; Wei Tan; Bingyan Li; Haixiang Zhou; Zicong Wang; Jingling Zou; Chun Ding; Bing Jiang; Shigeo Yoshida; Yedi Zhou
Journal:  Front Microbiol       Date:  2021-08-26       Impact factor: 5.640

Review 7.  Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg.

Authors:  Allan Langlois; Aurore Dumond; Julie Vion; Michel Pinget; Karim Bouzakri
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

Review 8.  The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications.

Authors:  Geng-Hao Bai; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.048

Review 9.  The role of lipopolysaccharides in diabetic retinopathy.

Authors:  Xinran Qin; Haidong Zou
Journal:  BMC Ophthalmol       Date:  2022-02-22       Impact factor: 2.209

Review 10.  Reciprocal interactions between gut microbiota and autophagy.

Authors:  Pierre Lapaquette; Jean-Baptiste Bizeau; Niyazi Acar; Marie-Agnès Bringer
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.